ISSN 2234-5531
Case Reports
  |     |     |   Journal of K orean Epilepsy Society_17_1_22_23.pdf
Journal of K orean Epilepsy Society 2013 June;17(1):22-23.
Published online 2013 October 14
Copyright ⓒ 2010 Journal of Korean Epilepsy Society
Oxcarbazepine에 의한 백혈구 감소증
손유리⋅김영수⋅주 건⋅이상건
서울대학교 의과대학 신경과학교실
Corresponding Author: Sang-Kun Lee, MD, PhD ,Tel: +82-2-2072-2923, Fax: +82-2-3672-7553, Email:
Oxcarbazepine (OXC) is generally assumed to be safe with regard to the risk for adverse hematopoietic effects. Recently, pancytopenia and leukopenia associated with the treatment of OXC have been reported. However, that serious adverse effect has never been reported in Korea. We describe a case of 47-year-old woman with temporal lobe epilepsy who developed reversible leukopenia following OXC monotherapy. She stopped to take OXC and WBC count was normalized completely.
Keywords: Oxcarbazepine, Adverse effects, Leukopenia

Copyrightⓒ Korean Epilepsy Scoiety. All right reserved.
KCC Parktown 101-308, Mallijae-ro 185, Jung-Gu, Seoul, Korea
Tel : +82-70-7591-3489 Fax : +82-2-6969-9608 E-mail :